colorectalLongi | R Documentation |
Randomly chosen 150 patients from the follow-up of the FFCD 2000-05 multicenter phase III clinical trial originally including 410 patients with metastatic colorectal cancer randomized into two therapeutic strategies: combination and sequential. The dataset contains measurements of tumor size (left-censored sums of the longest diameters of target lesions; transformed using Box-Cox) with baseline characteristics(treatment arm, age, WHO performance status and previous resection).
data(colorectalLongi)
This data frame contains the following columns:
identification of each subject. Repeated for each recurrence
time of visit counted in years from baseline
Individual longitudinal measurement of transformed
(Box-Cox with parameter 0.3) sums of the longest diameters, left-censored
due to a detection limit (threshold s=-3.33
).
To which treatment arm a patient was allocated? 1: sequential (S); 2: combination (C)
Age at baseline: 1: <50 years, 2: 50-69 years, 3: >69 years
WHO performance status at baseline: 1: status 0, 2: status 1, 3: status 2
Previous resection of the primate tumor? 0: No, 1: Yes
We thank the Federation Francophone de Cancerologie Digestive and Gustave Roussy for sharing the data of the FFCD 2000-05 trial supported by an unrestricted Grant from Sanofi.
Ducreux, M., Malka, D., Mendiboure, J., Etienne, P.-L., Texereau, P., Auby, D., Rougier, P., Gasmi, M., Castaing, M., Abbas, M., Michel, P., Gargot, D., Azzedine, A., Lombard- Bohas, C., Geoffroy, P., Denis, B., Pignon, J.-P., Bedenne, L., and Bouche, O. (2011). Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial. The Lancet Oncology 12, 1032-44.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.